Efficacy of cephalexin two vs. three times daily vs. cefadroxil once daily for streptococcal tonsillopharyngitis

Clinical Pediatrics

Volumn 42, Issue 6, 2003, Pages 519-526

  Curtin, Correne D ^a   Casey, Janet R ^a   Murray, Patrick C ^c   Cleary, Carolyn T ^a   Hoeger, William J ^a   Marsocci, Steven M ^a   Murphy, Marie Lynd ^a   Francis, Anne B ^a   Pichichero, Michael E ^a,b  

^a Elmwood Pediatric Group   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEFADROXIL; CEFALEXIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ARTICLE; BETA HEMOLYTIC STREPTOCOCCUS; CHILD; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; OPEN STUDY; PHARYNGITIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS INFECTION; TONSIL DISEASE; TREATMENT OUTCOME;

EID: 0038642306     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992280304200606     Document Type: Article

References (59)

1. Pickering LK, Peter G, Baker CJ, Gerber MA, MacDonald NE, Orenstein WA, Patriarca P, Committee on Infectious Diseases. 2000 Red Book: Report of the Committee on Infectious Diseases, 25th ed. Elk Grove Village, IL: American Academy of Pediatrics, 2002.
2. Kelkar PS, Li JT-C. Cephalosporin allergy. N Engl J Med. 2001;345:804-809.
3. Anne S, Reisman RE. Risk of administering cephalosporin antibiotics to patients with histories of penicillin allergy. Ann Allergy Asthma Immunol. 1995;74:167-170.
4. Pichichero ME, Pichichero DM. Diagnosis of penicillin, amoxicillin, and cephalosporin allergy: reliability of examination assessed by skin testing and oral challenge. J Pediatr. 1998; 132:137-143.
5. Norrby SR. Side effects of cephalosporins. Drugs. 1987;34(Suppl 2):105-120.
6. Lin RY. A perspective on penicillin allergy. Arch Intern Med. 1992;152:930-937.
7. Dajani A, Taubert K, Ferrieri P, Peter G, Shulman S, Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics. 1995;96:758-764.
8. Tarpay MM, Chartrand M, Cox A. The extended microbiology of group A streptococcal pharyngitis observations during a double-blind controlled study of cephalexin twice versus four-times daily. Infection. 1984; 12:181-184.
9. Barbhaiya RH, Shukla UA, Gleason CR, et al. Phase I study of multiple-dose cefprozil and comparison with cefaclor. Antimicrob Agents Chemother. 1990;34:1198-1203.
10. McCarty JM, Renteria A, Doyle CA, Durham SJ, Hamilton H, Wilber RB, for the Cefprozil Multicenter Study Group. Cefprozil vs. cefaclor in the treatment of pharyngitis and tonsillitis. Infect Med. 1992;9(Suppl C):33-43.
11. Randolph M. Clinical comparison of once-daily cefadroxil and thrice-daily cefaclor in the treatment of streptococcal pharyngitis. Chemotherapy. 1988;34:512-518.
12. Christenson JC, Swenson E, Gooch WM III, Herrod JN. Comparative efficacy and safety of cefprozil (BMY-28100) and cefaclor in the treatment of acute group A beta-hemolytic streptococcal pharyngitis. Antimicrob Agents Chemother. 1991;35:1127-1130.
13. McCarty JM. Comparative efficacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis. Eur J Clin Microbiol Infect Dis. 1994;13:846-850.
14. Stillerman M, Isenberg HD. Streptococcal pharyngitis therapy: comparison of cyclacillin, cephalexin, and potassium penicillin V. Antimicrob Agents Chemother. 1970;10:270-276.
15. Disney FA, Breese BB, Green JL, Talpey WB, Tobin JR. Cephalexin and penicillin therapy of childhood betahemolytic streptococcal infections. Postgrad Med J. 1971;47(Suppl):47-51.
16. Stillerman M, Isenberg HD, Moody M. Streptococcal pharyngitis therapy. Comparison of cephalexin, phenoxymethyl penicillin, and ampicillin. Am J Dis Child. 1972;123:457-461.
17. Gau DW, Horn RF, Solomon RM, Johnson P, Leigh DA. Streptococcal tonsillitis in general practice. A comparison of cephalexin and penicillin therapy. Practitioner. 1972;208:276-281.
18. Rabinovitch M, MacKenzie R, Brazeau M, Marks MI. Treatment of streptococcal pharyngitis. I. Clinical evaluation. Can Med Assoc J. 1973;108:1271-1274.
19. Matsen JM, Torstenson O, Siegel SE, Bacaner H. Use of available dosage forms of cephalexin in clinical comparison with phenoxymethyl penicillin and benzathine penicillin in the treatment of streptococcal pharyngitis in children. Antimicrob Agents Chemother. 1974;6:501-506.
20. Disney FA, Dillon H, Blumer JL, et al. Cephalexin and penicillin in the treatment of group A beta-hemolytic streptococcal throat infections. Am J Dis Child. 1992;146:1324-1327.
21. Ginsburg CM, McCracken GH Jr, Crow SD, Steinberg JB, Cope F. A controlled comparative study of penicillin V and cefadroxil therapy of group A streptococcal tonsillopharyngitis. J Int Med Res. 1980;8 (Suppl):82-86.
22. Ginsburg CM, McCracken GH Jr, Steinberg JB, et al. Treatment of Group A streptococcal pharyngitis in children. Results of a prospective, randomized study of four antimicrobial agents. Clin Pediatr (Phila). 1982; 21:83-88.
23. Henness DM. A clinical experience with cefadroxil in upper respiratory tract infection. J Antimicrob Chemother. 1982;10(Suppl B):125-135.
24. Pichichero ME, Disney FA, Aronovitz GH, Talpey WB, Green JL, Francis AB. Randomized, single-blind evaluation of cefadroxil and phenoxymethyl penicillin in the treatment of streptococcal pharyngitis. Antimicrob Agents Chemother. 1987;31:903-906.
25. Stromberg A, Schwan A, Cars O. Five versus ten days treatment of group A streptococcal pharyngotonsillitis: a randomized controlled clinical trial with phenoxymethylpenicillin and cefadroxil. Scand J Infect Dis. 1988;20:37-46.
26. Holm SE, Roos K, Stromberg A. A randomized study of treatment of streptococcal pharyngotonsillitis with cefadroxil or phenoxymethylpenicillin (penicillin V). Pediatr Infect Dis J. 1991; 10(10 Suppl):S68-71.
27. Milatovic D. Evaluation of cefadroxil, penicillin and erythromycin in the treatment of streptococcal tonsillopharyngitis. Pediatr Infect Dis J. 1991; 10(10 Suppl):S61-63.
28. O'Grady F, Lambert HP, Finch RG, Greenwood D. Antibiotic and Chemotherapy: Anti-infective Agents and Their Use in Therapy, 7th ed. New York: Churchill Livingstone, 1997:217-219; 256-267.
29. Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J. 1996;15(3):255-259.
30. Holm S, Henning C, Grahn E, Lomberg H, Staley H. Is penicillin the appropriate treatment for recurrent tonsillopharyngitis? Results from a comparative randomized blind study of cefuroxime axetil and phenoxymethylpenicillin in children. The Swedish study group. Scand J Infect Dis. 1996;27:221-228.
31. Roos K, Larsson P. Loracarbef versus phenoxymethylpenicillin in the treatment of recurrent streptococcal pharyngotonsillitis. Scand J Infect Dis. 1997;29:141-145.
32. Pichichero ME, Hoeger W, Marsocci SM, et al. Variables influencing penicillin treatment outcome in streptococcal tonsillopharyngitis. Arch Pediatr Adolesc Med. 1999;153:565-570.
33. Gerber MA, Randolph MF, DeMeo K, Feder HM Jr, Kaplan EL. Failure of once-daily penicillin V therapy for streptococcal pharyngitis. Am J Dis Child. 1989;143:153-155.
34. Disney FA, Hanfling MJ, Hausinger SA. Loracarbef (LY163892) vs. penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis. Pediatr Infect Dis J. 1992;11(8 Suppl): S20-26.
35. Block SL, Hedrick JA, Tyler RD. Comparative study of the effectiveness of cefixime and penicillin V for the treatment of streptococcal pharyngitis in children and adolescents. Pediatr Infect Dis J. 1992;11:919-925.
36. Dajani AS, Kessler SL, Mendelson R, Uden DL, Todd WM. Cefpodoxime proxetil vs. penicillin V in pediatric streptococcal pharyngitis/tonsillitis. Pediatr Infect Dis J. 1993;12:275-279.
37. Gooch WM 3rd, McLinn SE, Aronovitz GH, et al. Efficacy of cefuroxime axetil suspension compared with that of penicillin V suspension in children with group A streptococcal pharyngitis. Antimicrob Agents Chemother. 1993;37:159-163.
38. McCarty JM. Comparative efficacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis. Eur J Clin Microbiol Infect Dis. 1994;13:846-850.
39. Pichichero ME, McLinn SE, Gooch WM 3rd, Rodriquez W, Goldfarb J, Reidenberg BE. Ceftibuten vs. penicillin V in group A beta-hemolytic streptococcal pharyngitis. Member of the Ceftibuten Pharyngitis International Study Group. Pediatr Infect Dis J. 1995;14(7 Suppl):S102-107.
40. Nemeth MA, McCary J, Gooch WM 3rd, Henry D, Keyserling CH, Tack KJ. Comparison of cefdinir and penicillin for the treatment of streptococcal pharyngitis. Clin Ther. 1999;21:1525-1532.
41. Assem E, Vickers M. Tests for penicillin allergy in man. II. The immunological cross-reaction between penicillins and cephalosporins. Immunology. 1964; 27:255-269.
42. Anderson JA. Cross-sensitivity to cephalosporins in patients allergic to penicillin. Pediatr Infect Dis. 1986; 5:557-561.
43. Saxon A, Beall GN, Rohr AS, Adelman DC. Immediate hypersensitivity reactions to beta-lactam antibiotics. Ann Intern Med. 1987;107:204-215.
44. Abraham E. The chemistry of new antibiotics. Am J Med. 1965;39:692-696.
45. Flynn E. Biological and chemical studies of the cephalosporins. Antimicrob Agents Chemother. 1966;6:715-726.
46. Newton GG, Hamilton-Miller JM. Cephaloridine: chemical and biochemical aspects. Postgrad Med J. 1967; 43(Suppl):10-37.
47. Grieco M. Cross-allergenicity of the penicillins and the cephalosporins. Arch Intern Med. 1967;119:141-145.
48. Scholand JF, Tennebaum JI, Cerilli GJ. Anaphylaxis to cephalothin in a patient allergic to penicillin. JAMA. 1968;206:130-132.
49. Petz LD. Immunologic cross-reactivity between penicillins and cephalosporins: a review. J Infect Dis. 1978; 137(Suppl):S74-S79.
50. Mendelson LM, Ressler G, Rosen JP, Selcow JE. Routine elective penicillin allergy skin testing in children and adolescents; study of sensitization. J Allergy Clin Immunol. 1984;73(1 pt 1):76-81.
51. Pichichero ME, Pichichero DM. Selecting skin testing reagents to predict amoxicillin and cephalosporin allergy. Pediatr Asthma Allergy Immunol. 1997;11:79-93.
52. Pichichero ME. Cephalosporins are superior to penicillin for treatment of streptococcal tonsillopharyngitis: is the difference worth it? Pediatr Infect Dis J. 1993;12:268-274.
53. Pichichero ME, Green JL, Francis AB, et al. Recurrent group A streptococcal tonsillopharyngitis. Pediatr lnfect Dis J. 1998;17:809-815.
54. Steele RW, Estrada B, Begue RE, Mirza A, Travillion DA, Thompson MP. A double-blind taste comparison of pediatric antibiotic suspensions. Clin Pediatr. 1997;36:193-199.
55. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150:1881-1884.
56. Pichichero ME, Margolis PA. A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity. Pediatr Infect Dis J. 1991; 10:275-281.
57. Pichichero ME, Disney FA, Talpey WB, et al. Adverse and beneficial effects of immediate treatment of group A beta-hemolytic streptococcal pharyngitis in an emergency department. Pediatr Infect Dis J. 1986; 5:655.
58. El-Dahar NT, Nijazi SS, Rawashdeh NM, et al. Immediate vs. delayed treatment of group A beta-hemolytic streptococcal pharyngitis with penicillin V. Pediatr Infect Dis J. 1991;10: 126-130.
59. Gerber MA, Tanz RR, Kabat W, et al. Potential mechanisms for failure to eradicate group A streptococci from the pharynx. Pediatrics. 1999;104:911917.